PLCOSKIN CO.,LTD.

PLCOSKIN is an innovative medical device company specializing in regenerative medicine and soft tissue reconstruction. Based in Seoul, South Korea, the company develops advanced biomaterials designed to restore both function and aesthetics. The company’s flagship product, TissueDerm, is a hybrid mesh created using proprietary 3D printing technology that combines biodegradable polymers with collagen. TissueDerm provides immediate structural support upon application and is gradually absorbed as new tissue forms, enabling effective tissue regeneration. Utilized across multiple surgical fields—including plastic surgery, neurosurgery, and orthopedics—TissueDerm enhances tissue integration and reduces complications, helping surgeons achieve safer and more predictable outcomes. Recognized for its cutting-edge technology, PLCOSKIN received a CES 2024 Innovation Award, highlighting its significant global potential.